Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
558 20 |
Ultima descărcare din IBN: 2023-10-01 14:50 |
Căutarea după subiecte similare conform CZU |
616.379-008.64:617.12-008.46]-092-085 (1) |
Pathology of the digestive system. Complaints of the alimentary canal (1698) |
SM ISO690:2012 EŞANU, Valeriu, PALII, Ina, REVENCO, Ninel, VUDU, Lorina, COBEŢ, Valeriu. Afectarea cardiacă in diabetul zaharat. In: Buletin de Perinatologie, 2020, nr. 2(87), pp. 62-70. ISSN 1810-5289. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletin de Perinatologie | |||||
Numărul 2(87) / 2020 / ISSN 1810-5289 | |||||
|
|||||
CZU: 616.379-008.64:617.12-008.46]-092-085 | |||||
Pag. 62-70 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Introduction. Diabetes is one of cardiometabolic syndrome, considered as an important cardiovascular risk factor, having an signifi cant impact in cardiovascular morbidity and mortality. Th e aim. Raising awareness of cardiovascular disease in diabetic pathology. Material and methods. Analysis of recent bibliographic data aimed at presenting cardiovascular disease in diabetes. Results. Studies report cardiovascular impairment at subjects with diabetes. Diabetic cardiomyopathy is a distinct clinical entity and has clinical aspects ranging from asymptomatic to heart failure. Recognized diagnostic modalities are cardiac biomarkers, cardiac imaging and endomyocardial biopsy. Th ere are new therapies that are being developed, in addition to conventional ones, including microRNA estimation and stem cell therapies in its treatment and prevention. Conclusions. T e prevalence of diabetic cardiomyopathy increases in parallel with the increase of diabetes, respectively, it is necessary to implement prevention and treatment measures, aimed to reduce the risk of morbidity and premature mortality. |
|||||
Cuvinte-cheie diabetes, diabetic cardiomyopathy, сахарный диабет, диабетическая кардиомиопатия |
|||||
|